Pharmaceuticals

Opioids Industry Growth Insights: Revenue Forecast to 2030

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the opioids market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Opioids Market between 2026 and 2030?

The opioids market has experienced consistent expansion in its size over recent years. This market is projected to expand from $23.98 billion in 2025 to $24.63 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 2.7%. Historically, this expansion has been driven by factors such as post-surgical pain prevalence, rising cancer incidence, widespread opioid prescription practices, the limited availability of alternative pain therapies, and robust hospital-based opioid usage.

The opioids market is anticipated to experience consistent expansion over the upcoming years. By 2030, its valuation is projected to reach $28.59 billion, demonstrating a compound annual growth rate (CAGR) of 3.8%. This projected increase can be linked to several factors, including an expanding chronic pain demographic, the creation of safer opioid products, the broadening of palliative care provisions, enhanced regulatory clarity regarding controlled substances, and a growing need for effective pain management among older populations. Significant developments expected during this period involve the evolution of precision-guided opioid treatments, the incorporation of digital prescription monitoring, a move towards formulations designed to deter abuse, an increase in the availability of long-acting and extended-release opioids, and their increasing application in managing pain for cancer patients.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13021&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Opioids Market?

The expanding occurrence of chronic illnesses is anticipated to fuel the expansion of the opioids market in the future. Chronic diseases, also recognized as non-communicable diseases (NCDs), are long-duration health issues that usually develop gradually and last for a considerable time. These ailments frequently endure for many years or an entire lifetime and typically do not disappear naturally. The rising incidence of chronic diseases represents a significant contributor to the opioids market. With more individuals developing chronic conditions and suffering from persistent pain, the demand for opioids increases. The application of opioids in managing chronic diseases is an intricate and developing field of medicine, known for its effective pain relief. For example, data from June 2024, sourced from the National Health Service, a UK-based government body, revealed that 3,615,330 individuals registered with a GP received a diagnosis of non-diabetic hyperglycemia or pre-diabetes (a state characterized by elevated blood sugar not reaching diabetic levels) in 2023. This figure indicated an 18% rise from the 3,065,825 cases recorded in 2022. Consequently, the expanding occurrence of chronic diseases is propelling the growth of the opioids market.

How Is The Opioids Market Organized Into Various Segments?

The opioids market covered in this report is segmented –

1) By Product Type: Methadone, Codeine, Fentanyl, Oxycodone, Morphine, Hydrocodone, Other Product Types

2) By Receptor Binding: Strong Agonist, Mild To Moderate Agonist

3) By Basis Of Indication: Inflammatory Condition, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain

4) By Distribution Channel: Hospital, Retail Pharmacies, Online Pharmacies

5) By Application: Pain Management, Cough Treatment, Diarrhea Treatment

Subsegments:

1) By Methadone: Methadone Tablets, Methadone Oral Solution

2) By Codeine: Codeine Phosphate Tablets, Codeine Liquid Formulations

3) By Fentanyl: Fentanyl Patch, Fentanyl Injection, Fentanyl Sublingual Tablets

4) By Oxycodone: Oxycodone Tablets, Oxycodone Extended-Release Formulations

5) By Morphine: Morphine Sulfate Tablets, Morphine Injection, Morphine Extended-Release Capsules

6) By Hydrocodone: Hydrocodone/Acetaminophen Tablets, Hydrocodone Liquid Formulations

7) By Other Product Types: Buprenorphine, Tramadol, Other Combination Products

How Are New Market Trends Shaping The Landscape Of The Opioids Market?

Leading companies operating in the opioid market are concentrating on developing advanced drug therapies to solidify their position. The introduction of new medications can address illnesses, enhance healthcare, and advance scientific understanding. For example, in May 2023, Braeburn Pharmaceuticals Inc., a US-based firm offering solutions for opioid addiction treatment, declared that the US Food and Drug Administration had approved Brixadi (buprenorphine) extended-release injectable for subcutaneous administration (under the skin) for managing moderate to severe opioid use disorder (OUD). This product is the first and only weekly and monthly subcutaneous injection for moderate to severe OUD, and it is also the first buprenorphine injectable to utilize FluidCrystal Injection Depot Technology. Patients currently on oral buprenorphine-containing medications can be transitioned to equivalent dosages, provided the prescription guidelines are followed.

Who Are The Top-Performing Companies In The Opioids Market In Recent Years?

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca Plc, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals plc, Alkermes plc, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Which Region Currently Holds The Largest Share Of The Opioids Market?

North America was the largest region in the opioids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the opioids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Opioids Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13021&type=smp

Browse Through More Reports Similar to the Global Opioids Market 2026, By The Business Research Company

Opioids Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioids-global-market-report

Morphine Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/morphine-drugs-global-market-report

Opioid Use Disorder Oud Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795